Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty

Rashmi R. Shah, Peter D. Stonier
  • Therapeutic Advances in Drug Safety, June 2018, SAGE Publishing
  • DOI: 10.1177/2042098618780854
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: